NCT06225206View on ClinicalTrials.gov

Analysis of Donor-derived Cell Free DNA in Liver Transplant Patients

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Liver Transplant Failure
Interventions
BEHAVIORAL

donor-derived cell free DNA in liver

Determine the difference in age, gender, LFTs, IS regimen (tacrolimus/sirolimus/cyclosporin with mycophenolate mofetil (MMF) and /or prednisone) between patients who underwent liver transplant \<1 year PTX and \>1 year PTX

Trial Locations (1)

75203

RECRUITING

Methodist Dallas Medical Center, Dallas

All Listed Sponsors
lead

Methodist Health System

OTHER